ÜBER DIESE EPISODE

Englisch
Vereinigte Staaten

TRANSKRIPT 🔗

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Kelley Drye Ad Law Access Podcast durchsuchen.

WEITERE EPISODEN IN DIESEM PODCAST

What happens when an FDA advisory committee recommends opening the door to peptide compounding, but FDA staff strongly disagree? In this episode, we unpack the FDA Pharmacy Compounding Advisory Committee’s recommendation to add six of seven peptides under review to the 503A Bulks List for uses rang…
What are state attorneys general preparing to tackle next—and what should businesses be watching? In this episode, we recap key takeaways from the 2026 Attorneys General Alliance Annual Meeting, where state AGs, regulators, and industry leaders focused on the rapid evolution of AI, privacy, pricing…
What’s the difference between hard-hitting marketing and misleading pricing claims? In this episode, we unpack a recent NAD decision involving Harry’s and Gillette that explores the boundaries of comparative advertising, including when advertisers can rely on regular retail prices instead of tempor…
What happens when the FTC says “cancel” should actually mean cancel? In this episode, we unpack the FTC’s lawsuit against Uber, which alleges the company enrolled consumers in its Uber One subscription without obtaining proper consent, made misleading savings claims, and created an unnecessarily co…
What did July reveal about the future of advertising law and consumer protection? In this Summer Edition of the Ad Law Access Podcast, we take a step back from the month’s individual developments to explore the bigger trends shaping the legal landscape, from the application of traditional advertisi…
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Kelley Drye Advertising Law, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.